Dr. Martens commands a high Ebitda multiple with its IPO

Dr. Martens logo

Dr. Martens is being valued between £3.3-3.7 billion (€3.7bn-$4.5bn to €4.2bn-$5.1bn) in its planned public offering on the London Stock Exchange, whichis already fully booked. The valuation implies a multiple of over 17 times Ebitda, as the company generated Ebitda of £184 million (€204.2m-$248.3m) on revenues of £672 million (€745.8m-$907m) ...

SIGN-IN if you are already a subscriber of SGI Europe - or Register a free account

Gated access promo

Start your 30-day trial for just €9.90

Get access to what the top decision makers are reading in the sporting goods industry:

  • Analysis across Retail, Sustainability, Technology, Corporate and M&A, Financial Development, Market and Trends, Legal & Regulation, Trade & Sourcing and more
  • Essential E-mail Briefings with the latest analysis and most important industry developments
  • Find inspiration to drive your business forward with our case studies and best practices on business opportunities
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry

For team or company-wide subscriptions and enquiries see our corporate membership page.